Compare · CHRN vs DHR
CHRN vs DHR
Side-by-side comparison of ChronoScale Holdings Corporation (CHRN) and Danaher Corporation (DHR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHRN and DHR operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DHR is the larger of the two at $159.24B, about 107.6x CHRN ($1.48B).
- DHR has been more active in the news (23 items in the past 4 weeks vs 1 for CHRN).
- DHR has more recent analyst coverage (25 ratings vs 0 for CHRN).
- Company
- ChronoScale Holdings Corporation
- Danaher Corporation
- Price
- -
- -
- Market cap
- $1.48B
- $159.24B
- 1M return
- -
- +5.82%
- 1Y return
- -
- +9.11%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 1
- 23
- Recent ratings
- 0
- 25
ChronoScale Holdings Corporation
ChronoScale Holdings Corporation is being formed to become an accelerated compute platform purpose-built to support the most demanding artificial intelligence workloads. To be formed through the strategic business combination of Applied Digital Cloud and EKSO, ChronoScale is expected to deliver scalable GPU-based infrastructure optimized for AI training, inference, and high-performance computing, leveraging a proven operating foundation designed for performance, reliability, and rapid deployment.
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Latest CHRN
Latest DHR
- SEC Form SCHEDULE 13G filed by Danaher Corporation
- Why the Next Edge in Antibody Discovery May Be What Labs Remember
- Integrated DNA Technologies and Aldevron Launch New mRNA Solutions to Simplify Base and Prime Editing
- Director Dewan Feroz was granted 144 phantom shares (SEC Form 4)
- Director Zerhouni Elias A. was granted 199 phantom shares (SEC Form 4)
- Director Filler Linda was granted 15 phantom shares (SEC Form 4)
- Director Stevens Raymond C was granted 153 phantom shares (SEC Form 4)
- Director List Teri was granted 13 phantom shares (SEC Form 4)
- Director Sanders A Shane was granted 178 phantom shares (SEC Form 4)
- Director Spoon Alan G was granted 193 phantom shares (SEC Form 4)